Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate specific antigen: an updated review.

Alan So1, Larry Goldenberg, Martin E Gleave

  • 1Division of Urology, University of British Columbia, The Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.

The Canadian Journal of Urology
|January 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.

Endocrine oncology (Bristol, England)·2026
Same author

PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges.

Cells·2026
Same author

The predictive value of lesion density in enhancing multiparametric MRI for detecting clinically significant prostate cancer.

Urologic oncology·2026
Same author

Reply by Authors.

The Journal of urology·2025
Same author

Comparative analysis of apixaban vs. enoxaparin for thromboprophylaxis after radical cystectomy A single-center, observational, before-after study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025
Same author

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update).

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025
Same journal

Smarter, Not More: The Rationale for Reducing Systematic Cores in the MRI-Targeted Biopsy Era.

The Canadian journal of urology·2026
Same journal

Ten Years of Progress in Advanced Prostate Cancer at the AUA.

The Canadian journal of urology·2026
Same journal

Electroacupuncture for sperm improvement in varicocele: a case report.

The Canadian journal of urology·2026
Same journal

Transperineal approach for penetrating injury of corpus spongiosum and bulbous urethra caused by vesicourethral foreign body: a case report.

The Canadian journal of urology·2026
Same journal

Penile fracture and concomitant severe urethral trauma-a case report and discussion of surgical approach.

The Canadian journal of urology·2026
Same journal

Management of retained bullet fragments from posterior urethra after gunshot wound: a case report.

The Canadian journal of urology·2026
See all related articles

Serum prostate-specific antigen (PSA) testing aids in managing prostate cancer, offering insights into tumor characteristics and prognosis. This review examines PSA

Area of Science:

  • Urology
  • Oncology

Background:

  • Serum prostate-specific antigen (PSA) has been a cornerstone in prostate cancer management since its 1979 discovery.
  • PSA screening is recommended by North American medical bodies as a shared decision-making process.
  • Beyond screening, PSA aids in predicting tumor volume, stage, and prognosis pre- and post-treatment.

Purpose of the Study:

  • To review the effectiveness of PSA testing in prostate cancer diagnosis and management.
  • To evaluate recent literature on PSA derivatives and alternative prostate cancer markers.

Main Methods:

  • Literature review of PSA testing and its applications.
  • Evaluation of studies on PSA derivatives (proPSA, bPSA) and hk2.

Main Results:

Related Experiment Videos

  • PSA testing has significantly impacted prostate cancer management.
  • Ongoing debate surrounds PSA screening efficacy and implementation.
  • Emerging PSA derivatives and markers show potential for improved diagnostic accuracy.

Conclusions:

  • Serum PSA remains a vital tool in prostate cancer care.
  • Shared decision-making is crucial for PSA screening implementation.
  • Further research into PSA derivatives and novel markers is warranted for enhanced prostate cancer detection and management.